![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
X
20
Selborne Biological Services (australia) Pty. Ltd. Longford Au, based in Australia, is a pharmaceutical company.
One of their significant offerings is Newborn Calf Serum, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2001-137 - Rev 01
This TSE Type CEP, issued on September 13, 2011, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.